# Protalix BioTherapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 10-K/A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 06:47 ET
- Period: 2022-12-31
- Accession: 0001558370-23-007386
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837023007386/plx-20221231x10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837023007386/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837023007386/plx-20221231x10ka.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-007386. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
